Background Hyperhomocysteinaemia is an independent risk factor in the development of cardiovascular disease. Although homocysteine has been shown to affect endothelial cell function, the mechanisms by which it induces disease states are still poorly understood. Here, we report the ability of homocysteine to influence inflammatory cytokine/chemokine production by human saphenous vein endothelial cells, peripheral blood monocytes and monocyte-derived macrophages.
Introduction
Homocysteine is a sulphur-containing amino acid formed during the metabolism of methionine. 1 Elevated plasma concentration of total homocysteine has emerged as an independent risk factor, not only in the development of atherosclerosis but also in other vascular disorders such as arterial and venous thrombosis, stroke and myocardial infarction. 2 Vascular endothelial cells regulate the vascular tone, act as a non-thrombogenic barrier, produce and secrete various growth factors, cytokines, chemokines and basement membrane components, function as a permeability barrier, and internalize and modify lipoproteins via lipoprotein receptors. According to the response-to-injury hypothesis, atherogenesis is initiated as a result of initial injury (e.g. mechanical, chemical, toxic, viral) mainly to the vascular endo-thelium of the arterial wall. 3 During the early stages of atherogenesis, and despite maintenance of structural integrity, endothelial dysfunction/activation is commonly observed. 4 Activated endothelial cells have been shown to upregulate adhesion molecules responsible for the selective recruitment of monocytes and T-lymphocytes such as intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), and release various cytokines, chemokines and growth factors including interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin-8 (IL-8) and macrophage chemo-attractant protein-1 (MCP-1). 5^7 This process results in an ampli¢cation of leukocyte accumulation and activation at the injury site. Once activated, leukocytes produce a wide range of cytokines, chemokines and growth factors, which contribute to the attraction of additional monocytes and vascular smooth muscle cells, stimulate smooth muscle cell proliferation and induce extracellular matrix formation. 8 Tumour necrosis factor-a (TNF-a), IL-1 and IL-6 are cytokines that are upregulated during in£ammatory events, while IL-8 is a chemokine that plays a central role in leucocyte recruitment during in£ammation. Additionally, activated macrophages can express metalloproteinases and tissue factor, which in turn play an important role in determining plaque stability and thrombogenicity. 9 Although the mechanisms by which homocysteine can induce vascular dysfunction are not fully understood, 1,10 a number of studies have indicated that homocysteine may contribute to the development and progression of atherosclerosis by enhancing leucocyte adhesion and migration, stimulating smooth muscle proliferation and increasing the expression of MCP-1. 11^14 High circulating concentrations of homocysteine may activate endothelial cells and leucocytes, converting them to pro-in£ammatory phenotypes. Thus, homocysteine-induced stimulation of cytokine and chemokine production and associated increases in adhesion and migration of leucocytes may play a central role in the development and progression of atherosclerotic lesions in hyperhomocysteinaemic states. In this study, we investigated the potential pro-in£ammatory activity of homocysteine by assessing its e¡ect on in£ammatory cytokine and chemokine production by human saphenous vein endothelial cells, blood monocytes and monocytederived macrophages.
Methods

Human saphenous vein endothelial cells (HSVECs)
were isolated from segments of human saphenous veins left over from cardiac bypass surgery at Leeds General In¢rmary, Leeds, UK. Human serum was obtained from the Blood Bank, She¤eld, UK. Collagenase type II, Lymphoprep, penicillin/streptomycin, fungizone and L-glutamine were obtained from Gibco (Paisley, UK). Medium 199, D,L-homocysteine, and lipopolysaccharide were obtained from Sigma (Dorset, UK). To assay human IL-1b, IL-6, IL-8 and TNF-a, Biosource enzyme-ampli¢ed sensitivity immunoassay (EASIA TM ) kits were used, obtained from Lifescreen (Appligene Oncor),Watford, UK.
Isolation of human saphenous vein endothelial cells
An enzymatic technique was used to isolate the HSVECs, adapted from the method described by Ja¡e et al. 15 Brie£y, following £ushing of vein with phosphate-bu¡ered saline (PBS) to remove blood, the vein lumen was perfused with 0.1% collagenase type II, clamped and then incubated at 378C for 13 min. At the end of the incubation period, the contents of the vein were £ushed out with PBS. The cell suspension was centrifuged at 200 g to obtain a cell pellet. Cells were subsequently maintained in medium 199 containing 20% human serum and supplemented with penicillin/ streptomycin (100 U/100 mg/mL), fungizone (2.5 mg/ mL) and L-glutamine (2 mmol/ L). The purity of all endothelial cell cultures was assessed both morphologically and by their ability to express the characteristic endothelial cell markers CD31and vonWillebrand factor. Cells in passages 3-6 were used throughout this study.
Isolation of monocytes
Human peripheral blood monocytes (HPBMs) were isolated by Ficoll-Hypaque density gradient centrifugation (density 1.077 g/mL). Brie£y, blood was collected by venepuncture from healthy volunteers. Blood was diluted with PBS and carefully layered onto Lymphoprep and then centrifuged at 600 g for 25 min. The mononuclear cells at the interface were carefully removed and diluted three-to fourfold with PBS. This cell suspension was subsequently centrifuged at 600 g for 10 min. This step was repeated twice in order to wash the cells, which were then ¢nally re-suspended in medium 199 supplemented with 20% human serum, L-glutamine (2 mmol/ L) and penicillin/streptomycin (100 U/100 mg/mL), and the total cell concentration was adjusted to 2610 6 cells/mL. This cell suspension was then added to the required number of wells of a 6-or 24-well plate and incubated at 378C under 5% CO 2 . The monocytic fraction of the mononuclear cells was further puri¢ed by allowing them to adhere to the tissue culture plastic for approximately 1h. 16 
Maturation of human peripheral blood monocytes to macrophages
To obtain human monocyte-derived macrophages (HMDMs), isolated human peripheral blood monocytes were maintained in culture at 378C under 5% CO 2 for 7 days, during which they matured and acquired functional characteristics. 17 During this maturation period, the media in the cultures were changed every 72 h.
Effects of homocysteine on human saphenous vein endothelial cell, peripheral blood monocyte and monocyte-derived macrophage function
Homocysteine solutions were made in complete media (5 mmol/ L, 1 mmol/ L, 0.5 mmol/ L and 0.1 mmol/ L D,L-homocysteine) and immediately added to con£uent monolayers of either HSVECs (1.2610 5 cells/mL; 500 mL/well), HPBMs (2610 6 cells/mL; 1mL/well) or HMDMs (2610 6 cells/mL; 1mL/well), in 24-well plates. The cells were then incubated for a further 4 h or 24 h at 378C. Monocytes, macrophages and HSVECs were also incubated in media only (control experiments) or stimulated with lipopolysaccharide (LPS) (100 ng/mL) for 4 h and/or 24 h. At the end of the incubations, media from duplicate wells were collected on ice, pooled, centrifuged at 13 000 g for 2 min, and then immediately aliquoted and stored at 7808C until further analysis by enzyme-linked immunosorbent assay (ELISA). In order to correct for variation in cell concentrations between experiments, following each experiment cells were trypsinized, cell concentrations were determined and cytokine production was normalized for the number of cells. Experiments were repeated up to 11, nine and four times using di¡erent HSVEC cell lines, HPBM and HMDM preparations, respectively.
Measurement of tumour necrosis factor-a, interleukin-1b, interleukin-6 and interleukin-8 protein
Release of the in£ammatory cytokines TNF-a, IL-1b and IL-6 and the chemokine IL-8 was assessed by measuring their concentrations in media obtained from the experiments previously mentioned. EASIA TM ELISA kits were used for quantitative measurements of TNF-a, IL-1b, IL-6, IL-8 and MCP-1. Collection, storage and assays were all carried out according to the manufacturer's instructions provided with each kit.
Assessment of cell viability and morphology
At the end of all experiments, cells were counted using a haemocytometer. Cell viability was evaluated in all experimental conditions by Trypan Blue exclusion and was found to be greater than 95% for all experiments. Phase -contrast microscopy was also used to assess morphological changes at the end-point of each treatment.
Statistical analysis
Statistical analysis for all experiments was carried out using the SPSS statistical software package (SPSS Inc, Chicago, USA). All data were initially tested using the Kolmogorov^Smirnov test to determine whether they were normally distributed. Data were subsequently analysed using the parametric Student's paired samples t-test. Di¡erences were considered statistically signi¢cant if P values were 50.05.
Results
Effect of homocysteine on cytokine and chemokine production by human saphenous vein endothelial cells
Tumour necrosis factor-a was not detected in the media obtained from resting, homocysteine-(0.1-5 mmol/ L D,L-homocysteine) or LPS-(100 ng/mL) stimulated HSVECs.
Interleukin-6 was produced by resting HSVECs (157+31 and 657+96 pg/mL after 4 and 24 h, respectively) and production was increased by LPS (100 ng/mL) stimulation (696+134 and 3415+ 420 pg/mL after 4 and 24 h, respectively). Figure 1(a) shows the e¡ect of homocysteine on IL-6 production. Homocysteine did not have a signi¢cant e¡ect on IL-6 production by HSVECs following the 4-h incubation, but IL-6 production increased following 24-h treatment with the highest concentration of homocysteine (5 mmol/ L).
Interleukin-8 was also produced by resting HSVECs (1058+258 and 3521+638 pg/mL after 4 and 24 h, respectively) and production was increased by LPS (100 ng/mL) stimulation (2645+411 and 5864+ 834 pg/mL after 4 and 24 h, respectively). Figure 1 short-(4 h) and long-(24 h) term treatment. The inhibition was less profound when the cells were treated over a longer period of time (24 h). Figure 2(a) shows TNF-a production by HPBMs following 4-h or 24-h incubation with homocysteine. Tumour necrosis factor-a was detected in media obtained from resting cells (1064+336 and 1534+928 pg/mL after 4 and 24 h, respectively) and its concentration was increased in media from LPS-(100 ng/mL) stimulated cells (9848+2369 and 18 684+8859 pg/mL after 4 and 24 h, respectively). Although TNF-a concentrations were found to increase following both the short-and long-term homocysteine treatments, these di¡erences failed to reach statistical signi¢cance.
Effect of homocysteine on cytokine and chemokine production by human peripheral blood monocytes
Interleukin-1bwas detected in media of resting cells (3575+1839 and 1887+1236 pg/mL following 4 and 24 h, respectively) and its concentration was increased in media from LPS-(100 ng/mL) stimulated cells (6646+3112 and 8851+3187 pg/mL after 4 and 24 h, respectively). The e¡ect of homocysteine on IL-1b production is summarized in Fig. 2(b) . Short-term (4 h) treatment of HPBMs with homocysteine failed to produce statistically signi¢cant e¡ects, but long-term treatment (i.e. 24 h) resulted in a signi¢cant stimulation of IL-1b production, ranging from 180 -290%, as compared with control cells (see Fig. 2b ).
Interleukin-6 was also detected in the media obtained from control cells (10776+3272 and19 976+ 6138 pg/mL at 4 and 24 h, respectively) and its concentration was increased in media from LPS-(100 ng/mL) stimulated cells (27 938+4097 concentrations of IL-6 following homocysteine treatment (see Fig. 2c ). Interleukin-8 was detected in the media of control cells (17 111+2507 and 25 765+5390 pg/mL at 4 and 24 h, respectively) and its concentration was increased in media from LPS-(100 ng/mL) stimulated cells (20 412+2591and 44 384+12 887 pg/mL after 4 and 24 h, respectively). Figure 2(d) shows IL-8 production by HPBMs following the homocysteine treatment. A small stimulation in IL-8 concentrations was observed following both short-(4 h) and longterm (24 h) treatments.
Effect of homocysteine on cytokine and chemokine production by human monocyte-derived macrophages
Human monocyte-derived macrophages were found to produce TNF-a, IL-1b, IL-6 and IL-8 under resting conditions (81+28, 87+79, 68+51 and 2182+ 782 pg/mL, respectively) and their concentration was increased in the media of cells stimulated with LPS for 24 h (8770+5623, 107+0.41, 3780+3461 and 196+ 71 pg/mL, respectively).
Homocysteine was found to have an overall stimulatory e¡ect on the concentration of TNF-a, IL-1b, IL-6 and IL-8, following a 24-h stimulation with a range of concentrations (1-5 mmol/ L), the e¡ect being more profound for TNF-a and IL-6 (see Fig. 3 ).
Effect of homocysteine on human saphenous vein endothelial cell, human peripheral blood monocyte and human monocyte-derived macrophage morphology
Following short-and long-term treatments (i.e. 4 and 24 h) with high concentrations of homocysteine (5 mmol/ L), the HSVECs, HPBMs and HMDMs became elongated (see Figs 4 and 5) . These changes in morphology were not observed in control cells or when cells were treated with LPS or lower concentrations of homocysteine (0.1, 0.5 or 1mmol/ L).
Discussion
Hyperhomocysteinaemia is an independent risk factor in the development of cardiovascular disease. 1, 10 Various genetic and acquired factors contribute to an increase in homocysteine concentrations, including defects in the key regulatory enzymes and vitamin co-factors. Although it has been shown that homocysteine in£uences a number of parameters contributing to the development of atherosclerosis, it is not yet clear whether increased homocysteine concentration is the cause or a manifestation of other underlying disorders. Similarly, the mechanisms by which elevated concentrations of homocysteine can a¡ect vascular cell function are still poorly understood. Thus, in this study, the ability of homocysteine to a¡ect in£ammatory cytokine and chemokine production by endothelial cells, monocytes and monocyte-derived macrophages, and therefore to contribute to the recruitment, activation and adhesion of leukocytes, were investigated.
A potential role for endothelial dysfunction in hyperhomocysteinaemia has been highlighted in a number of studies. In response to elevated concentrations of homocysteine in vitro, pathological changes in endothelial function resulting in pro-thrombotic and pro-adhesive potential have been reported. 13,18^21 Homocysteine has also been shown to induce speci¢c changes in gene expression in human umbilical vein endothelial cells (HUVECs), altering their cellular anti-oxidant potential 22 and nuclear factor-kb (NFkb) activation. 23 Human saphenous vein endothelial cells are derived from adult saphenous veins and therefore constitute an excellent model to study the responses of adult endothelium, as opposed to the frequently used embryonic cells.
Human saphenous vein endothelial cells did not produce TNF-a under resting conditions or following LPS or homocysteine stimulation. Our ¢ndings are in agreement with a recent study by Poddar et al. 14 reporting that homocysteine also failed to induceTNFa and IL-1b mRNAs in human aortic endothelial cells. Interleukin-6 and IL-8 were found to be constitutively produced by HSVEC, and homocysteine stimulated IL-6 and inhibited IL-8 production (see Fig. 1 ). Interleukin-6 can play an important role in priming both monocytes and neutrophils, and has been shown to enhance lymphocyte binding to HUVECs, increase vascular muscle cell proliferation and contribute to the activation of the coagulation cascade, 21, 22 whilst IL-8 is mainly involved in the recruitment of neutrophils in acute in£ammation. Overall, these observations may in part represent a mechanism by which homocysteine can contribute to the pathogenesis of atherosclerosis.
Tumour necrosis factor-a, IL-1b, IL-6 and IL-8 were constitutively produced by HPBMs and HMDMs. Production by HPBMs was more than 10-fold greater than that of HMDMs, an observation consistent with the results of Koga et al. 24 Homocysteine stimulated TNF-a production by HMDMs (see Fig. 3 ) and IL-1b production by HPBMs (see Fig. 2 ). The pleiotropic cytokine TNF-a has been shown to increase adhesion of leucocytes to the endothelium and enhance cytokine and chemokine release and metalloproteinase production, 25^27 and the presence of TNF-a mRNA and protein have been demonstrated in human coronary atherosclerotic plaque tissue. 28 Therefore, the homocysteine-induced TNF-a production may play an important role in mediating plaque development and progression in vivo.
Homocysteine was not found to a¡ect IL-6 production by either HPBMs or HMDMs (see Fig. 2 ). However, it has been reported that homocysteine increased IL-6 production by the monocytic cell line Mono Mac 6 after a long-time treatment (3 days). 29 Hence, it is possible that a longer stimulation with homocysteine may be required to maximally activate pathways involved in IL-6 production in monocytes and macrophages. Furthermore, functional changes in cell lines do not always re£ect those observed in freshly isolated cells. Therefore, our results may partially be explained by the fact that the monocytes used in the present study were from a number of di¡erent donors. Failure of the observed changes to reach statistical signi¢cance may re£ect the subject variability and di¡erent Generally, the concentrations of homocysteine used for in vitro studies (mmol/L to mmol/ L range) have not always re£ected concentrations detected in vivo (mmol/ L). However, it has been reported that endothelial cells isolated from normal individuals are relatively resistant to the e¡ects of homocysteine and hence may require higher doses to increase intracellular uptake and enable the cellular factors that in£uence the metabolism and/or elimination of homocysteine to be overcome. 18, 20, 22 Thus, concentrations of homocysteine ranging from pathophysiological (0.1 mmol/ L) to relatively higher (5 mmol/ L) were utilized in this study. However, as D,L-homocysteine was used for the treatments, the e¡ective homocysteine concentrations were actually half of those reported.
The observed changes in HSVEC morphology (see Fig. 4 ) are in agreement with similar ¢ndings for endothelial cells. 19, 20 These changes could be attributed to cytoskeletal re-arrangements occurring as a response to homocysteine-induced oxidative stress. 30 The signi¢cance of the morphological changes in HPBMs and HMDMs (see Fig. 5 ) is uncertain; however, it is known that reorganization of the cytoskeleton plays a role in respiratory burst activity in monocytes. 31 The pleiotropic cytokine TNF-a has been shown to in£uence processes involved in the development and progression of atherosclerotic lesions. The pro-in£ammatory cytokine IL-1b shares many of these functions. 25^27 Therefore, the homocysteine-induced upregulation of IL-1b in monocytes and of TNF-a in macrophages could account for its atherogenic properties. However, IL-6 and IL-8 have both been reported to have pro-and anti-in£ammatory activities. 32 The homocysteine-induced upregulation of those two mediators of in£ammation in endothelial cells needs to be further explored in healthy and diseased tissues in order to elucidate the potential atherogenic or protective e¡ect it may exercise.
Overall, results from this study suggest that homocysteine alters the pro¢le of cytokine and chemokine production by endothelial cells and macrophages. This altered pro¢le may be important in the in£ammatory events that initiate or enhance the development of atherosclerotic lesions. Of interest was the change in morphology and the down-regulation of IL-8 production by HSVECs, which suggested that homocysteine may promote selective recruitment of speci¢c leucocyte subpopulations which play a role in the chronic in£ammation process seen in the development of atherosclerosis. During the course of this study, only the e¡ects of acute stimulation with homocysteine on the in£ammatory responses of HSVECs, HPBMs and HMDMs were investigated. Although these studies lend an insight into the potential mechanisms by which homocysteine may induce vascular cell dysfunction, of future interest would be an understanding of how long-term or chronic stimulation with pathophysiologically relevant concentrations of homocysteine could a¡ect the functional responses of endothelial cells and their interactions with di¡erent leucocyte subpopulations.
